نتایج جستجو برای: metronomic chemotherapy

تعداد نتایج: 114478  

Journal: :Current Oncology 2009
O.G. Scharovsky L.E. Mainetti V.R. Rozados

The introduction of the "maximum tolerated dose" in usual treatment protocols (and its concomitant overt toxicity) made necessary the imposition of rest periods between cycles of therapy-a practice that not only involves re-growth of tumour cells, but also growth of selected clones resistant to the therapy. To avoid the problems caused by traditional chemotherapeutic regimens, a new modality of...

2014
Anna Koumarianou Maria-Ioanna Christodoulou Pavlos Patapis Iordanis Papadopoulos Elissavet Liakata Athina Giagini Anastasia Stavropoulou Nikiforita Poulakaki Nikolaos Tountas Nikolaos Xiros Theophanis Economopoulos Dimitris Pectasides Ourania E Tsitsilonis Vassiliki Pappa

BACKGROUND The host's immune system is crucially involved in cancer development and progression. The ratio of regulatory to effector T-cells, as well as the interplay of T-cells with therapeutic agents, impact on cancer prognosis. The current study aimed to comparatively investigate the effect of metronomic and standard chemotherapy on the number and functionality of peripheral regulatory and e...

Journal: :FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2015
Samantha Russell Mark Duquette Joyce Liu Ronny Drapkin Jack Lawler Jim Petrik

Most women are diagnosed with epithelial ovarian cancer (EOC) at advanced stage, where therapies have limited effectiveness and the long-term survival rate is low. We evaluated the effects of combined antiangiogenic and chemotherapy treatments on advanced stage EOC. Treatment of EOC cells with a recombinant version of the thrombospondin-1 type I repeats (3TSR) induced more apoptotic cell death ...

2017
Irina Kareva

Therapeutic resistance remains a major obstacle in treating many cancers, particularly in advanced stages. It is likely that cytotoxic lymphocytes (CTLs) have the potential to eliminate therapy-resistant cancer cells. However, their effectiveness may be limited either by the immunosuppressive tumor microenvironment, or by immune cell death induced by cytotoxic treatments. High-frequency low-dos...

2018
Nengping Zhu Rongsheng Qin Qin Zhang Shaozhi Fu Shanshan Liu Yue Chen Juan Fan Yunwei Han

Metronomic chemotherapy in combination with immunotherapy is an attractive approach in cancer therapy. The purpose of the present study was to investigate the anti-tumor effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with metronomic paclitaxel (MET PTX) on Lewis lung carcinoma transplanted in mice. In the present study, tumor-bearing mice survival time and tu...

2016
Paolo Tralongo Sebastiano Bordonaro Annamaria Di Mari Francesco Cappuccio Sebastiano Rametta Giuliano

BACKGROUND In elderly patients affected by metastatic castration-resistant prostate cancer (mCRPC) chemotherapic treatment may be the choice if one considers not only the chronological age, but also the clinical status, the functional reserve, and the vulnerability of patients. Several studies have confirmed the survival benefit of docetaxel and vinorelbine among every class of age. Most CRP el...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
Guido Bocci Giulio Francia Shan Man Jack Lawler Robert S Kerbel

Chemotherapeutic drugs chronically administered to tumor-bearing mice, using a frequent schedule at doses substantially lower than the maximum tolerated dose (MTD) (i.e., metronomic dosing), can cause sustained and potent antiangiogenic effects by targeting the endothelial cells of newly growing tumor blood vessels. These effects appear to occur in the absence of an increase in the severity of ...

2016
Pan Pantziarka Lisa Hutchinson Nicolas André Sébastien Benzekry Francesco Bertolini Atanu Bhattacharjee Shubhada Chiplunkar Dan G. Duda Vikram Gota Sudeep Gupta Amit Joshi Sadhana Kannan Robert Kerbel Mark Kieran Antonella Palazzo Aparna Parikh Eddy Pasquier Vijay Patil Kumar Prabhash Yuval Shaked Giselle Saulnier Sholler Jaroslav Sterba David J. Waxman Shripad Banavali

The 5th Biennial Metronomic and Anti-angiogenic Therapy Meeting was held on 6th - 8th May in the Indian city of Mumbai. The meeting brought together a wide range of clinicians and researchers interested in metronomic chemotherapy, anti-angiogenics, drug repurposing and combinations thereof. Clinical experiences, including many from India, were reported and discussed in three symposia covering b...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Sun Joo Lee Sukhen C Ghosh Hee Dong Han Rebecca L Stone Justin Bottsford-Miller De Yue Shen Edmond J Auzenne Alejandro Lopez-Araujo Chunhua Lu Masato Nishimura Chad V Pecot Behrouz Zand Duangmani Thanapprapasr Nicholas B Jennings Yu Kang Jie Huang Wei Hu Jim Klostergaard Anil K Sood

PURPOSE Most primary human ovarian tumors and peritoneal implants, as well as tumor vascular endothelial cells, express the CD44 family of cell surface proteoglycans, the natural ligand for which is hyaluronic acid. Metronomic dosing, the frequent administration of chemotherapeutics at substantially lower than maximum tolerated doses (MTD), has been shown to result in reduced normal tissue toxi...

2016
Eirini Biziota Evangelos Briasoulis Leonidas Mavroeidis Marios Marselos Adrian L. Harris Periklis Pappas

Metronomic oral vinorelbine (VRL; Navelbine) was shown in clinical trials to yield sustainable antitumor activity possibly through antiangiogenic mechanisms. We investigated the effects of protracted low-dose VRL on human umbilical vein endothelial cells, compared with a conventional chemotherapy model. Human umbilical vein endothelial cell cultures were treated with different concentrations of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید